• 1. Fatty acid positional distribution in colostrum and mature milk of women living in Inner Mongolia, North Jiangsu and Guangxi of China?
  Long Deng,Qian Zou,Biao Liu,Wenhui Ye,Chengfei Zhuo,Li Chen,Ze-Yuan Deng,Ya-Wei Fan,Jing Li Food Funct., 2018,9, 4234-4245
• 2. Enantio- & chemo-selective preparation of enantiomerically enriched aliphatic nitro alcohols using Candida parapsilosis ATCC 7330
  Sowmyalakshmi Venkataraman RSC Adv., 2015,5, 73807-73813
• 3. Fast-Track to Research Data Management in Experimental Material Science-Setting the Ground for Research Group Level Materials Digitalization.
  LarsBanko,AlfredLudwig
• 4. Fatty acid eutectic mixtures and derivatives from non-edible animal fat as phase change materials?
  Pau Gallart-Sirvent,Marc Martín,Gemma Villorbina,Mercè Balcells,Aran Solé,Luisa F. Cabeza,Ramon Canela-Garayoa RSC Adv., 2017,7, 24133-24139
• 5. Evidence of rutile-to-anatase photo-induced electron transfer in mixed-phase TiO2 by solid-state NMR spectroscopy?
  Weili Dai,Guangjun Wu,Michael Hunger Chem. Commun., 2015,51, 13779-13782

• Solvents and Organic Chemicals Organic Compounds Organic nitrogen compounds Organonitrogen compounds N-organohydroxylamines

Methanamine,N-methoxy-N-methyl- (9CI) and Its Significance in Modern Chemical Research

Methanamine,N-methoxy-N-methyl- (9CI), with the CAS number 5669-39-6, is a compound that has garnered significant attention in the field of chemical biology and pharmaceutical research. This compound, often referred to by its systematic name, plays a crucial role in the synthesis of various bioactive molecules and has been explored in numerous academic and industrial studies. The structural uniqueness of Methanamine,N-methoxy-N-methyl- (9CI) makes it a valuable intermediate in the development of novel therapeutic agents.

The chemical structure of Methanamine,N-methoxy-N-methyl- (9CI) consists of a methanamine backbone with N-methoxy and N-methyl substituents. This configuration imparts unique reactivity and functional properties, making it a versatile building block in organic synthesis. The presence of both electron-withdrawing and electron-donating groups enhances its utility in forming complex molecular architectures, which is particularly relevant in drug discovery efforts.

In recent years, the pharmaceutical industry has shown increasing interest in Methanamine,N-methoxy-N-methyl- (9CI) due to its potential applications in the synthesis of small molecule inhibitors. These inhibitors are being actively investigated for their efficacy against various diseases, including cancer and neurodegenerative disorders. The compound's ability to act as a precursor for biologically active molecules has made it a focal point in medicinal chemistry research.

One of the most compelling aspects of Methanamine,N-methoxy-N-methyl- (9CI) is its role in the development of enzyme inhibitors. Enzyme inhibition is a key strategy in drug design, as many therapeutic agents work by binding to specific enzymes and modulating their activity. The structural features of Methanamine,N-methoxy-N-methyl- (9CI) allow it to interact with enzyme active sites, making it a promising candidate for creating selective inhibitors. For instance, studies have demonstrated its potential in inhibiting kinases, which are overactive in many cancer cell lines.

Another area where Methanamine,N-methoxy-N-methyl- (9CI) has shown promise is in the synthesis of neurotransmitter receptor modulators. Neurotransmitter receptors play a critical role in neurological functions, and modulating their activity can lead to novel treatments for conditions such as depression, anxiety, and epilepsy. The compound's ability to mimic or interfere with neurotransmitter binding has been explored in preclinical studies, highlighting its therapeutic potential.

The synthesis of Methanamine,N-methoxy-N-methyl- (9CI) involves multi-step organic reactions that require precise control over reaction conditions. Advanced synthetic methodologies, such as catalytic hydrogenation and nucleophilic substitution reactions, are commonly employed to achieve high yields and purity. The development of efficient synthetic routes is essential for scaling up production and making the compound more accessible for research purposes.

Recent advancements in computational chemistry have also contributed to the understanding of Methanamine,N-methoxy-N-methyl- (9CI)'s properties. Molecular modeling techniques allow researchers to predict how the compound interacts with biological targets at the atomic level. This computational approach complements experimental studies and accelerates the drug discovery process. By integrating experimental data with computational insights, scientists can design more effective derivatives of Methanamine,N-methoxy-N-methyl- (9CI) with enhanced biological activity.

The environmental impact of synthesizing Methanamine,N-methoxy-N-methyl- (9CI) is another important consideration. Green chemistry principles are being increasingly adopted to minimize waste and reduce energy consumption during production. Techniques such as solvent-free reactions and catalytic processes are being explored to make the synthesis more sustainable. These efforts align with global initiatives to promote environmentally friendly chemical practices.

In conclusion, Methanamine,N-methoxy-N-methyl- (9CI) is a compound of significant interest in modern chemical research due to its versatile applications in pharmaceuticals and biochemical studies. Its unique structural features enable it to serve as a key intermediate in drug development, particularly for enzyme inhibitors and neurotransmitter receptor modulators. As research continues to uncover new synthetic methods and applications, the importance of Methanamine,N-methoxy-N-methyl- (9CI) is likely to grow further, contributing to advancements in medicine and biotechnology.

• 2098070-20-1(2-(3-(Pyridin-3-yl)-1H-pyrazol-1-yl)acetimidamide)
• 2680771-01-9(4-cyclopentyl-3-{(prop-2-en-1-yloxy)carbonylamino}butanoic acid)
• 1444113-98-7(N-(3-cyanothiolan-3-yl)-2-[(2,2,2-trifluoroethyl)sulfanyl]pyridine-4-carboxamide)
• 332062-08-5(Fmoc-S-3-amino-4,4-diphenyl-butyric acid)
• 1270529-38-8(1,2,3,4,5,6-Hexahydro-[2,3]bipyridinyl-6-ol)
• 941977-17-9(N'-(3-chloro-2-methylphenyl)-N-2-(dimethylamino)-2-(naphthalen-1-yl)ethylethanediamide)
• 2138166-62-6(2,2-Difluoro-3-[methyl(2-methylbutyl)amino]propanoic acid)
• 89640-58-4(2-Iodo-4-nitrophenylhydrazine)
• 1449132-38-0(3-Fluoro-5-(2-fluoro-5-methylbenzylcarbamoyl)benzeneboronic acid)
• 2034271-14-0(2-(1H-indol-3-yl)-N-{[6-(thiophen-2-yl)-[1,2,4]triazolo[4,3-b]pyridazin-3-yl]methyl}acetamide)